Holiday House, founded in 2008 by interior designer and breast cancer survivor Iris Dankner, is an interior design showhouse where top interior designers and lifestyle brands showcase their talent to raise critical funds for the prevention and cure of breast cancer.
Due to the COVID-19 pandemic, Holiday House Hamptons has made the decision to cancel their 2020 showhouse and produce a Virtual Showhouse published by Hamptons Magazine in an effort to continue raising critical funds for breast cancer research and keep the design community and visitors engaged and safe during the summer months.
Iris Dankner was inspired to combine her two passions — interior design and fundraising for breast cancer research — when she saw a lack of high profile interior design events in the New York City area benefitting this great cause. After its inception in 2008, Holiday House became the first designer show house in New York City to benefit a breast cancer organization, attracting talented designers from across the country to transform the historic Academy Mansion on Manhattan’s Upper East Side each fall. Following its success in New York, Holiday House created a summer expansion in the Hamptons and is now established as one of the premiere show houses in the country.
In 2017, Holiday House celebrated its tenth year of showhouses with the 10th annual Holiday House NYC at the Academy Mansion in NYC, the inaugural Holiday House London, and the launch of Holiday House: Ten Years of Decorating for a Cure, a beautiful coffee table book documenting Holiday House’s history from Pointed Leaf Press. Iris also celebrated twenty years as a survivor!
Iris currently serves as a member on the advisory board of The Breast Cancer Research Foundation® (BCRF) while her interior design show house, Holiday House, directly benefits the organization. Since partnering with The Breast Cancer Research Foundation® (BCRF), Holiday House has granted over one million dollars to this renowned charity that invests 91 cents of every dollar to support its mission of ending breast cancer by advancing the world’s most groundbreaking research.